Physician profile
James M Elmore
NPI 1336174085
$1,522.98
in general payments reported to CMS, 2019-2025
16 companies · $58.68 in 2025
The $58.68 reported for 2025 was less than what a typical Pediatric Urology provider received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.86 · 2021: $76.13 · 2022: $1,047 · 2023: $152 · 2024: $108 · 2025: $58.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $319.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $766.99 | 2022 | |
| Boston Scientific Corporation | $227.05 | 2022 | |
| Mdd US Operations, LLC | $144.29 | 2023-2024 | Gocovri, Gocovri |
| Bayer Healthcare Pharmaceuticals INC. | $80.52 | 2021-2024 | |
| Palette Life Sciences, INC. | $59.51 | 2019 | |
| Novo Nordisk INC | $42.40 | 2024 | |
| Dendreon Pharmaceuticals LLC | $33.50 | 2024 | Provenge |
| Dentsply Ih INC. | $25.93 | 2021 | |
| Merck Sharp & Dohme LLC | $25.63 | 2023 | Lynparza, Welireg, Keytruda |
| Octapharma USA, INC. | $22.52 | 2025 | Panzyga |
| Calyxo, INC. | $21.05 | 2025 | Cvac Aspiration System |
| Allergan, INC. | $20.04 | 2019 | |
| Axonics, INC. | $17.30 | 2022 | |
| Abc Home Medical Supply, INC. | $16.01 | 2022 | |
| Coloplast Corp | $15.11 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $5.13 | 2019-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Elmore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.